Company profile
Gnubiotics Sciences SA
Gnubiotics Sciences SA is revolutionizing the microbiome health of humans and animals with a new category of complex molecules: glycans. Gnubiotics' unique and proprietary technology platform combines the power of chemistry and genomics to develop glycans that are proving to have unparalleled efficacy in restoring microbiome equilibrium, enabling the host to harness its power.
Source: startup.ch
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
